Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Kevin James Croce, M.D.,Ph.D.

Co-Author

This page shows the publications co-authored by Kevin Croce and Galina Sukhova.
Connection Strength

0.392
  1. Myeloid-related protein-8/14 is critical for the biological response to vascular injury. Circulation. 2009 Aug 04; 120(5):427-36.
    View in: PubMed
    Score: 0.109
  2. Targeted delivery of Protein Arginine Deiminase-4 inhibitors to limit arterial intimal NETosis and preserve endothelial integrity. Cardiovasc Res. 2021 Mar 05.
    View in: PubMed
    Score: 0.061
  3. S100A9-RAGE Axis Accelerates Formation of Macrophage-Mediated Extracellular Vesicle Microcalcification in Diabetes Mellitus. Arterioscler Thromb Vasc Biol. 2020 08; 40(8):1838-1853.
    View in: PubMed
    Score: 0.058
  4. Roles of PAD4 and NETosis in Experimental Atherosclerosis and Arterial Injury: Implications for Superficial Erosion. Circ Res. 2018 06 22; 123(1):33-42.
    View in: PubMed
    Score: 0.050
  5. Flow Perturbation Mediates Neutrophil Recruitment and Potentiates Endothelial Injury via TLR2 in Mice: Implications for Superficial Erosion. Circ Res. 2017 Jun 23; 121(1):31-42.
    View in: PubMed
    Score: 0.047
  6. Systemic delivery of microRNA-181b inhibits nuclear factor-?B activation, vascular inflammation, and atherosclerosis in apolipoprotein E-deficient mice. Circ Res. 2014 Jan 03; 114(1):32-40.
    View in: PubMed
    Score: 0.036
  7. Selective inhibition of matrix metalloproteinase-13 increases collagen content of established mouse atherosclerosis. Arterioscler Thromb Vasc Biol. 2011 Nov; 31(11):2464-72.
    View in: PubMed
    Score: 0.032
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.